3Soerjomataram I, Lortet Tieulent J, Parkin DM, et al. Global burden of cancer in-2008: a systematic analysis of disability adjusted life years in-12 world regions[J]. Lancet,2012,380:1840-1850.
4Chen H, Liang C, Zhang L, et al. Clinical efficacy of modified preoperative neoadjuvant chemotherapy in the treatment of locally advanced (stage ⅠB2 to ⅡB) cervical cancer: randomized study[J]. Gynecol Oncol,2008,110:308-315.
5Tsubamoto H, Maeda H, Kanazawa R, et al. Phase Ⅱ trial on neoadjuvant intravenous and trans uterine arterial chemotherapy for locally advanced bulky cervical adenocarcinoma[J]. Gynecol Oncol,2013,129:129-134.
6Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin- based chemoradiation improves progression free and overall survival in advanced cervical cancer: resuhs of a randomized Gynecologic Oncology Group study[ J~. N Engl J Med, 1999, 340(15) : 1144-1153.
7Resbeut M, Cowen D, Viens P, et al. Concomitant chemoradi- ation prior to surgery in the treatment of advanced cervical carcinoma[ J 1. Gynecol Oncol, 1994,54 ( 1 ) :68-75.
8Jurado R, Lopez-Flores A, Alvarez A, et al. Cisplatin cytotox- icity is increased by mifepristone in cervical carcinoma:an in vitro and in vivo study[ J). Oncology Reports,2009,22 (5) : 1237-1245.
9Mancuso S, Smaniotto D, Panici PB, et al. Phase I - lI trial of preoperative chemoradiation in locally advanced cervical carcinoma [ J 3. Gynecologic Oncology, 2000, 78 ( 3 ) : 324- 328.
10Albuquerque K, Giangreco D, Morrison C, et al. Radiation-related predictors of hematologic toxicity after concurrent chemoradiation for cervical cancer and implications for bone marrowsparing pelvic IMRT[J]. Int J Radiat Oncol Biol Phys, 2011, 79 (4) : 1043-1047.
